Delayed treatment of MS is associated with high CSF levels of IL-6 and IL-8 and worse future disease course
Clinical deterioration of relapsing–remitting MS (RR-MS) patients reflects not only the number and severity of overt inflammatory and demyelinating episodes, but also subtle central damage caused by persistent exposure to inflammatory molecules.
To explore the correlation between levels of CSF inflammatory molecules at the time of diagnosis and both demographic and clinical characteristics of a large sample of RR-MS patients, as well as the predictive value of cytokine levels on their prospective disease course.
In 205 patients diagnosed with RR-MS, we measured at the time of diagnosis the CSF levels of inflammatory molecules. Clinical and MRI evaluation was collected at the time of CSF withdrawal and during a median follow-up of 3 years.
The time interval between the first anamnestic episode of focal neurological dysfunction and RR-MS diagnosis was the main factor associated with high CSF levels of IL-6 and IL-8. Furthermore, elevated CSF levels of these cytokines correlated with enhanced risk of clinical and radiological disease reactivation, switch to second-line treatments, and with disability progression in the follow-up.
Delayed diagnosis and treatment initiation are associated with higher CSF levels of IL-6 and IL-8 in RR-MS, leading to worsening disease course and poor response to treatments.
KeywordsRR-MS CSF cytokines IL-6 IL-8 Neuroinflammation Disease activity
The present study was supported by the Italian Ministry of Health (Ricerca Corrente), and by the 5 × 1000 grant to IRCCS Neuromed.
MSB: conception and design of the study, drafting a significant portion of the manuscript or figures. EI: conception and design of the study, drafting a significant portion of the manuscript or figures. DL: acquisition and analysis of data. FM: acquisition and analysis of data. LG: acquisition and analysis of data. IS: statistical analysis of data. AM: acquisition and analysis of data. GM: acquisition and analysis of data. FV: acquisition and analysis of data. RF: analysis of data. AF: analysis of data. GAM: acquisition and analysis of data. DC: conception and design of the study, drafting a significant portion of the manuscript or figures. FB: conception and design of the study, drafting a significant portion of the manuscript or figures.
Compliance with ethical standards
Conflicts of interest
On behalf of all authors, the corresponding author states that there is no conflict of interest.
- 19.Matsushita T, Tateishi T, Isobe N et al (2013) Characteristic cerebrospinal fluid cytokine/chemokine profiles in neuromyelitis optica, relapsing remitting or primary progressive multiple sclerosis. PLoS One 8:e61835. https://doi.org/10.1371/journal.pone.0061835 CrossRefPubMedPubMedCentralGoogle Scholar
- 24.Kappos L, Polman CH, Freedman MS et al (2006) Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes. Neurology 67:1242–1249. https://doi.org/10.1212/01.wnl.0000237641.33768.8d CrossRefPubMedGoogle Scholar
- 25.Kappos L, Freedman MS, Polman CH et al (2009) Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial. Lancet Neurol 8:987–997. https://doi.org/10.1016/S1474-4422(09)70237-6 CrossRefPubMedGoogle Scholar